Skip to main content
Autobound logo

AbbVie news in 2026: 34 dated events

The latest AbbVie event on this page is dated Sep 29, 2026. finance.yahoo.com reported: AbbVie Teams Up With Valkai to Use AI in Clinical Development.

Public (ABBV)Pharmaceutical Manufacturing10,000+ employeesabbvie.comLinkedIn

Dated events
34
Last 90 days
19
Latest
Sep 29, 2026

News · latest 10

Latest AbbVie news

  1. Partnership
    AbbVie Teams Up With Valkai to Use AI in Clinical DevelopmentAbbVie has partnered with life sciences AI platform Valkai to deploy artificial intelligence technology to improve efficiency in clinical research and reduce development timelines.
    finance.yahoo.com
  2. Integration
    Valkai partners with AbbVie to apply advanced AI in targeted areas of clinical developmentAbbVie will deploy AI capabilities from Valkai to improve efficiency in targeted areas of clinical research.
    ch.zonebourse.com
  3. Launch
    U.S. FDA Approves AbbVie's JUVMO™ (tavapadon) for Parkinson's DiseaseAbbVie's Parkinson's disease treatment, JUVMO™ (tavapadon), has been approved by the U.S. Food and Drug Administration (FDA) and is expected to be available to patients in the U.S. in October 2026.
    prnewswire.com
  4. Launch
    AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic ArthritisAbbVie's drug RINVOQ (upadacitinib) received approval from the European Commission for treating active polyarticular juvenile idiopathic arthritis in patients aged two and older.
    prnewswire.com
  5. Partnership
    AbbVie partners with Iambic in AIAbbVie has entered into a multi-year partnership with Iambic to accelerate the discovery and development of innovative drug molecules in immunology, neurobiology, and oncology.
    ch.marketscreener.com
  6. Investment
    Drug developer ADARx seeks $1.74 billion valuation in US IPO$100M · With ADARx Pharmaceuticals · 2 stories
    sg.finance.yahoo.com
  7. In development
    AbbVie to Present Phase 3 Etentamig Results and Data from Broad Multiple Myeloma Portfolio at the 2026 International Myeloma Society (IMS) MeetingAbbVie is developing ABBV-2001 (ISB 2001), a CD38 x BCMA x CD3 trispecific T-cell engager, as part of its multiple myeloma pipeline.
    prnewswire.com
  8. Partnership
    AbbVie Named Official Pharmaceutical Sponsor of the PGA TOUR and 2026 Presidents Cup, Launches Birdies for Brain Health CampaignAbbVie and the PGA TOUR announced a partnership naming AbbVie the Official Pharmaceutical Sponsor of the PGA TOUR and the 2026 Presidents Cup.
    prnewswire.com
  9. In development
    AbbVie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual MigraineAbbVie announced positive topline results from its Phase 3 LUNA study for atogepant, a preventive treatment for menstrual migraine in adults, which met its primary endpoint and all eight ranked secondary endpoints.
    prnewswire.com
  10. Earnings
    AbbVie Inc. stock gains on Apogee deal and reaffirmed 2026 guidanceAbbVie reaffirmed its adjusted EPS guidance for fiscal year 2026 at USD 13.87 to USD 14.07.
    ad-hoc-news.de

Showing 10 of 34 dated events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track AbbVie with the Signal API

One POST /v1/companies/enrich call with abbvie.com returns AbbVie news signals (news), each with its source. Or ask Claude through MCP.

Start Free1,000 free creditsUse it in Claude via MCP

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"abbvie.com","signal_types":["news"],"limit":20}'

Same industry

News at related companies

Questions about AbbVie news

What is the latest news on AbbVie?
The newest event on this page is dated Sep 29, 2026. finance.yahoo.com reported: AbbVie Teams Up With Valkai to Use AI in Clinical Development. This page lists 34 dated events for AbbVie, each with a source link.
What is going on with AbbVie?
The 10 latest events on this page cover partnership (3), integration (1), launch (2), investment (1), in development (2) and earnings (1). The newest: Sep 29, 2026: AbbVie Teams Up With Valkai to Use AI in Clinical Development (finance.yahoo.com).

Source. News articles about the company, one source link per event.

Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.

Data as of .

How this data is built →Get it from the Signal API →